Overview of Roles of Novel Components in the Regulation of DNA Damage Repair in BRCA1-Deficient Cancers: An Update
Cancers that arise from germline mutations of breast cancer associated gene 1 (<i>BRCA1</i>), which is a crucial player in homologous recombination (HR) DNA repair, are vulnerable to DNA-damaging agents such as platinum and PARP inhibitors (PARPis). Increasing evidence suggests that BRCA...
Saved in:
| Main Authors: | Nhat Nguyen, Dominic Arris, Manh Tien Tran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | DNA |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-8856/5/2/17 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EEPD1 regulates inflammation and endothelial apoptosis in atherosclerosis through KLF4‐EEPD1‐ERK axis
by: Kaiwen Yu, et al.
Published: (2025-04-01) -
Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors
by: Romain Pacaud, et al.
Published: (2025-01-01) -
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
by: Marta Castroviejo‐Bermejo, et al.
Published: (2018-10-01) -
Ivosidenib Confers BRCAness Phenotype and Synthetic Lethality to Poly (ADP-Ribose) Polymerase Inhibition in <i>BRCA1/2</i>-Proficient Cancer Cells
by: Danyang Zhou, et al.
Published: (2025-04-01) -
Targeting BARD1 suppresses a Myc-dependent transcriptional program and tumor growth in pancreatic ductal adenocarcinoma
by: Sohum Patel, et al.
Published: (2025-05-01)